Purchase Order 75D30121P10258
Award Date
12/23/20
Potential Completion Date
3/30/21
Potential Value
$600K
Federal Agency
CDC Pittsburgh
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Other Statutory Authority
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Centers for Disease Control and Prevention awarded a $3.975 million firm fixed price definitive contract to Illumina, Inc. of San Diego, California. The contract is for SARS-COV-2 SPHERES Baseline Genomic Sequencing to support the Department of Health and Human Services and CDC's efforts responding to the Coronavirus Disease 2019 (COVID-19) pandemic. Under this contract, Illumina will provide genomic sequencing and data analysis services to establish a baseline of SARS-CoV-2 virus genomes...
Illumina, Inc. has been awarded a $97,020 firm fixed price purchase order by the Centers for Disease Control and Prevention (CDC) for an Illumina MiSeq sequencing system. The place of performance is in San Diego, California. No set-aside provision was applied to this acquisition. The CDC is a component of the Department of Health and Human Services that conducts research and provides guidance related to public health issues such as infectious diseases. This purchase will support the CDC's...
The Centers for Disease Control and Prevention (CDC) awarded a firm-fixed-price purchase order to Illumina, Inc. for $128,657.11 to provide whole genome sequencing kits. The award has an ultimate completion date of September 30, 2024. This award was made under an unrestricted solicitation, RFQ 75D301-24-Q-77983, which sought commercial items related to whole genome sequencing for antimicrobial resistance surveillance, including NovaSeq 6000 SP Reagent Kits, NovaSeq XP 2-Lane Kits, ILMN DNA LP...
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a Firm Fixed Price purchase order to Illumina, Inc., a manufacturer of sequencing and genomic analysis solutions, for the provision of lab supplies. The $16,168.00 contract has an April 29, 2024 completion date and was awarded on August 22, 2019. The lab supplies are to be delivered to the CDC's location in Atlanta, GA. Illumina is a for-profit organization and manufacturer that has previously...
The Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents, for reagents to be used with Illumina's sequencing systems. The $219,192.00 contract does not have a set-aside designation and is intended to support the CDC's needs through August 31, 2022. Illumina has a history of providing sequencing equipment, consumables, and services to...
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm fixed price purchase order contract to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $22,376.85 contract is for the provision of an ISEQ 100 SYSTEM, with a completion date of March 1, 2026. This award does not have a set-aside designation. Illumina has previously received prime federal contracts from agencies such as the NIH,...
This firm fixed-price purchase order contract was awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents, to facilitate the relocation of equipment to accommodate COVID-19 (CORVD) operations. The $20,092.00 contract has an ultimate completion date of August 1, 2024. Illumina has a history of providing sequencing systems and associated services to support genomic research and diagnostics across various...
The Centers for Disease Control and Prevention (CDC) awarded a $7,303.60 firm fixed price purchase order to Illumina, Inc. to provide supplies in support of the agency's programs. The contract has a period of performance from August 14, 2023 through September 10, 2023 and will be performed in San Diego, California. As the prime contractor, Illumina will deliver supplies to the CDC's Pittsburgh location. No major subcontractors or set aside designations were identified. The funding supports the...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $233,447.32 firm fixed price contract to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract, which has no set-aside designation, is for MISEQ SUPPORT SERVICES with a period of performance ending on March 31, 2028. Illumina, which has a history of providing sequencing systems, reagents, and related services to federal agencies, will...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price Blanket Purchase Agreement (BPA) call to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis solutions, for the provision of lab supplies and reagents. The $149,220.97 contract does not have a set-aside designation and is intended to support the CDC's research and diagnostics needs in Atlanta, Georgia. Illumina has a history of providing a range of...